BLV-CoCoMo-qPCR: Quantitation of bovine leukemia virus proviral load using the CoCoMo algorithm

Retrovirology

Volumn 7, Issue 1, 2010, Pages

  Jimba, Mayuko ^a,b   Takeshima, Shin nosuke ^a   Matoba, Kazuhiro ^c   Endoh, Daiji ^d   Aida, Yoko ^a,b  

^a RIKEN   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL INSTITUTE OF LIVESTOCK AND GRASSLAND SCIENCE   (Japan)

^d RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE LEUKEMIA VIRUS;

EID: 78549239170     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-7-91     Document Type: Article

References (52)

1. Lloyd-Smith JO, George D, Pepin KM, Pitzer VE, Pulliam JR, Dobson AP, Hudson PJ, Grenfell BT. Epidemic dynamics at the human-animal interface. Science 2009, 326:1362-1367. 10.1126/science.1177345, 19965751.
2. Tapper ML. Emerging viral diseases and infectious disease risks. Haemophilia 2006, 12(Suppl 1):3-7. discussion 26-28, 10.1111/j.1365-2516.2006.01194.x, 16445811.
3. Endoh D, Mizutani T, Kirisawa R, Maki Y, Saito H, Kon Y, Morikawa S, Hayashi M. Species-independent detection of RNA virus by representational difference analysis using non-ribosomal hexanucleotides for reverse transcription. Nucleic Acids Res 2005, 33:e65. 10.1093/nar/gni064, 1074749, 15817564.
4. Rose TM, Schultz ER, Henikoff JG, Pietrokovski S, McCallum CM, Henikoff S. Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences. Nucleic Acids Res 1998, 26:1628-1635. 10.1093/nar/26.7.1628, 147464, 9512532.
5. Bartl S. Amplification using degenerate primers with multiple inosines to isolate genes with minimal sequence similarity. Methods Mol Biol 1997, 67:451-457.
6. Moonka D, Loh EY. A consensus primer to amplify both alpha and beta chains of the human T cell receptor. J Immunol Methods 1994, 169:41-51. 10.1016/0022-1759(94)90123-6, 7510755.
7. Rose TM, Henikoff JG, Henikoff S. CODEHOP (COnsensus-DEgenerate Hybrid Oligonucleotide Primer) PCR primer design. Nucleic Acids Res 2003, 31:3763-3766. 10.1093/nar/gkg524, 168931, 12824413.
8. Katoh K, Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief Bioinform 2008, 9:286-298. 10.1093/bib/bbn013, 18372315.
9. Gillet N, Florins A, Boxus M, Burteau C, Nigro A, Vandermeers F, Balon H, Bouzar AB, Defoiche J, Burny A, Reichert M, Kettmann R, Willems L. Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology 2007, 4:18. 10.1186/1742-4690-4-18, 1839114, 17362524.
10. Alexandersen S, Carpenter S, Christensen J, Storgaard T, Viuff B, Wannemuehler Y, Belousov J, Roth JA. Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol 1993, 67:39-52. 237335, 8380084.
11. Kettmann R, Meunier-Rotival M, Cortadas J, Cuny G, Ghysdael J, Mammerickx M, Burny A, Bernardi G. Integration of bovine leukemia virus DNA in the bovine genome. Proc Natl Acad Sci USA 1979, 76:4822-4826. 10.1073/pnas.76.10.4822, 413029, 228266.
12. Kettmann R, Deschamps J, Cleuter Y, Couez D, Burny A, Marbaix G. Leukemogenesis by bovine leukemia virus: proviral DNA integration and lack of RNA expression of viral long terminal repeat and 3' proximate cellular sequences. Proc Natl Acad Sci USA 1982, 79:2465-2469. 10.1073/pnas.79.8.2465, 346219, 6283527.
13. Kettmann R, Cleuter Y, Mammerickx M, Meunier-Rotival M, Bernardi G, Burny A, Chantrenne H. Genomic integration of bovine leukemia provirus: comparison of persistent lymphocytosis with lymph node tumor form of enzootic. Proc Natl Acad Sci USA 1980, 77:2577-2581. 10.1073/pnas.77.5.2577, 349445, 6248854.
14. Lagarias DM, Radke K. Transcriptional activation of bovine leukemia virus in blood cells from experimentally infected, asymptomatic sheep with latent infections. J Virol 1989, 63:2099-2107. 250626, 2539506.
15. Aida Y, Miyasaka M, Okada K, Onuma M, Kogure S, Suzuki M, Minoprio P, Levy D, Ikawa Y. Further phenotypic characterization of target cells for bovine leukemia virus experimental infection in sheep. Am J Vet Res 1989, 50:1946-1951.
16. Wang CT. Bovine leukemia virus infection in Taiwan: epidemiological study. J Vet Med Sci 1991, 53:395-398.
17. Monti GE, Frankena K, Engel B, Buist W, Tarabla HD, de Jong MC. Evaluation of a new antibody-based enzyme-linked immunosorbent assay for the detection of bovine leukemia virus infection in dairy cattle. J Vet Diagn Invest 2005, 17:451-457.
18. Kurdi A, Blankenstein P, Marquardt O, Ebner D. [Serologic and virologic investigations on the presence of BLV infection in a dairy herd in Syria]. Berl Munch Tierarztl Wochenschr 1999, 112:18-23.
19. Zaghawa A, Beier D, Abd El-Rahim IH, Karim I, El-ballal S, Conraths FJ, Marquardt O. An outbreak of enzootic bovine leukosis in upper Egypt: clinical, laboratory and molecular-epidemiological studies. J Vet Med B Infect Dis Vet Public Health 2002, 49:123-129.
20. Schoepf KC, Kapaga AM, Msami HM, Hyera JM. Serological evidence of the occurrence of enzootic bovine leukosis (EBL) virus infection in cattle in Tanzania. Trop Anim Health Prod 1997, 29:15-19. 10.1007/BF02632338, 9090010.
21. Tajima S, Aida Y. The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers. J Virol 2000, 74:10939-10949. 10.1128/JVI.74.23.10939-10949.2000, 113173, 11069988.
22. Tajima S, Takahashi M, Takeshima SN, Konnai S, Yin SA, Watarai S, Tanaka Y, Onuma M, Okada K, Aida Y. A mutant form of the tax protein of bovine leukemia virus (BLV), with enhanced transactivation activity, increases expression and propagation of BLV in vitro but not in vivo. J Virol 2003, 77:1894-1903. 10.1128/JVI.77.3.1894-1903.2003, 140974, 12525624.
23. Tajima S, Ikawa Y, Aida Y. Complete bovine leukemia virus (BLV) provirus is conserved in BLV-infected cattle throughout the course of B-cell lymphosarcoma development. J Virol 1998, 72:7569-7576. 110004, 9696855.
24. Moratorio G, Obal G, Dubra A, Correa A, Bianchi S, Buschiazzo A, Cristina J, Pritsch O. Phylogenetic analysis of bovine leukemia viruses isolated in South America reveals diversification in seven distinct genotypes. Arch Virol 2010, 155:481-489. 10.1007/s00705-010-0606-3, 20169372.
25. VanLeeuwen JA, Tiwari A, Plaizier JC, Whiting TL. Seroprevalences of antibodies against bovine leukemia virus, bovine viral diarrhea virus, Mycobacterium avium subspecies paratuberculosis, and Neospora caninum in beef and dairy cattle in Manitoba. Can Vet J 2006, 47:783-786. 1524833, 16933557.
26. Kobayashi S, Tsutsui T, Yamamoto T, Hayama Y, Kameyama K, Konishi M, Murakami K. Risk factors associated with within-herd transmission of bovine leukemia virus on dairy farms in Japan. BMC Vet Res 2010, 6:1. 10.1186/1746-6148-6-1, 2835688, 20055982.
27. Rodriguez SM, Golemba MD, Campos RH, Trono K, Jones LR. Bovine leukemia virus can be classified into seven genotypes: evidence for the existence of two novel clades. J Gen Virol 2009, 90:2788-2797. 10.1099/vir.0.011791-0, 19587134.
28. Coulston J, Naif H, Brandon R, Kumar S, Khan S, Daniel RC, Lavin MF. Molecular cloning and sequencing of an Australian isolate of proviral bovine leukaemia virus DNA: comparison with other isolates. J Gen Virol 1990, 71(Pt 8):1737-1746. 10.1099/0022-1317-71-8-1737, 2167927.
29. Asfaw Y, Tsuduku S, Konishi M, Murakami K, Tsuboi T, Wu D, Sentsui H. Distribution and superinfection of bovine leukemia virus genotypes in Japan. Arch Virol 2005, 150:493-505. 10.1007/s00705-004-0433-5, 15592894.
30. Tong S, Chern SW, Li Y, Pallansch MA, Anderson LJ. Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol 2008, 46:2652-2658. 10.1128/JCM.00192-08, 2519498, 18579717.
31. Lew A, Bock R, Miles J, Cuttell L, Steer P, Nadin-Davis S. Sensitive and specific detection of bovine immunodeficiency virus and bovine syncytial virus by 5' Taq nuclease assays with fluorescent 3' minor groove binder-DNA probes. J Virol Methods 2004, 116:1-9. 10.1016/j.jviromet.2003.10.006, 14715301.
32. Moens B, Lopez G, Adaui V, Gonzalez E, Kerremans L, Clark D, Verdonck K, Gotuzzo E, Vanham G, Cassar O, Gessain A, Vandamme AM, Van Dooren S. Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol 2009, 47:3682-3691. 10.1128/JCM.00781-09, 2772591, 19741085.
33. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, Bera O, Plumelle Y, Smadja D, Nicolas JC. Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. J Virol Methods 2002, 102:37-51. 10.1016/S0166-0934(01)00445-1, 11879691.
34. Inabe K, Ikuta K, Aida Y. Transmission and propagation in cell culture of virus produced by cells transfected with an infectious molecular clone of bovine leukemia virus. Virology 1998, 245:53-64. 10.1006/viro.1998.9140, 9614867.
35. Aida Y, Okada K, Onuma M. Antigenic regions defined by monoclonal antibodies on tumor-associated antigens of bovine leukemia virus-induced lymphosarcoma cells. Leuk Res 1993, 17:187-193. 10.1016/0145-2126(93)90064-R, 7679174.
36. Aida Y, Okada K, Ohtsuka M, Amanuma H. Tumor-associated M(r) 34,000 and M(r) 32,000 membrane glycoproteins that are serine phosphorylated specifically in bovine leukemia virus-induced lymphosarcoma cells. Cancer Res 1992, 52:6463-6470.
37. Aida Y, Okada K, Amanuma H. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma. Cancer Res 1993, 53:429-437.
38. Aida Y, Onuma M, Mikami T, Izawa H. Topographical analysis of tumor-associated antigens on bovine leukemia virus-induced bovine lymphosarcoma. Cancer Res 1985, 45:1181-1186.
39. Aida Y, Nishino Y, Amanuma H, Murakami K, Okada K, Ikawa Y. The role of tumor-associated antigen in bovine leukemia virus-induced lymphosarcoma. Leukemia 1997, 11(Suppl 3):216-218.
40. Tajima S, Zhuang WZ, Kato MV, Okada K, Ikawa Y, Aida Y. Function and conformation of wild-type p53 protein are influenced by mutations in bovine leukemia virus-induced B-cell lymphosarcoma. Virology 1998, 243:735-746. 10.1006/viro.1998.9051, 9540787.
41. Konnai S, Usui T, Ikeda M, Kohara J, Hirata T, Okada K, Ohashi K, Onuma M. Tumor necrosis factor-alpha genetic polymorphism may contribute to progression of bovine leukemia virus-infection. Microbes Infect 2006, 8:2163-2171. 10.1016/j.micinf.2006.04.017, 16839795.
42. Levy D, Deshayes L, Guillemain B, Parodi AL. Bovine leukemia virus specific antibodies among French cattle. I. Comparison of complement fixation and hematological tests. Int J Cancer 1977, 19:822-827. 10.1002/ijc.2910190613, 194846.
43. Miyasaka M, Reynolds J, Dudler L, Beya MF, Leiserson W, Trnka Z. Differentiation of B lymphocytes in sheep. II. Surface phenotype of B cells leaving the 'bursa-equivalent' lymphoid tissue of sheep, ileal Peyer's patches. Adv Exp Med Biol 1985, 186:119-126.
44. Onuma M, Koyama H, Aida Y, Okada K, Ogawa Y, Kirisawa R, Kawakami Y. Establishment of B-cell lines from tumor of enzootic bovine leukosis. Leuk Res 1986, 10:689-695. 10.1016/0145-2126(86)90274-2, 3012214.
45. Hughes SH, Shank PR, Spector DH, Kung HJ, Bishop JM, Varmus HE, Vogt PK, Breitman ML. Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell 1978, 15:1397-1410. 10.1016/0092-8674(78)90064-8, 215325.
46. Derse D, Diniak AJ, Casey JW, Deininger PL. Nucleotide sequence and structure of integrated bovine leukemia virus long terminal repeats. Virology 1985, 141:162-166. 10.1016/0042-6822(85)90193-X, 2983496.
47. Aida Y, Kohda C, Morooka A, Nakai Y, Ogimoto K, Urao T, Asahina M. Cloning of cDNAs and the molecular evolution of a bovine MHC class II DRA gene. Biochem Biophys Res Commun 1994, 204:195-202. 10.1006/bbrc.1994.2444, 7945359.
48. Zhao TM, Robinson MA, Bowers FS, Kindt TJ. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J Virol 1995, 69:2024-2030. 188867, 7884847.
49. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291. 253077, 3016298.
50. Guan Y, Whitney JB, Detorio M, Wainberg MA. Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted. J Virol 2001, 75:4056-4067. 10.1128/JVI.75.9.4056-4067.2001, 114151, 11287555.
51. Shackleford GM, Varmus HE. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci USA 1988, 85:9655-9659. 10.1073/pnas.85.24.9655, 282828, 2849114.
52. Ishimoto A, Takimoto M, Adachi A, Kakuyama M, Kato S, Kakimi K, Fukuoka K, Ogiu T, Matsuyama M. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses. J Virol 1987, 61:1861-1866. 254191, 3033317.